SUMO fusion system facilitates soluble expression and high production of bioactive human fibroblast growth factor 23 (FGF23)

As a key humoral regulator of phosphate homeostasis and its involvement in the pathogenesis of human disease, human fibroblast growth factor 23 (hFGF23) has become a particularly attractive therapeutic target. To prepare soluble and bioactive recombinant human FGF23 to meet the increasing demand in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Appl Microbiol Biotechnol
Egile Nagusiak: Liu, Xiaoju, Chen, Yubin, Wu, Xiaoping, Li, Haiyan, Jiang, Chao, Tian, Haishan, Tang, Lu, Wang, Dezhong, Yu, Ting, Li, Xiaokun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer-Verlag 2012
Gaiak:
Biotechnologically Relevant Enzymes and Proteins
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7080044/
https://ncbi.nlm.nih.gov/pubmed/22249722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00253-011-3864-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak